Yıl: 2023 Cilt: 45 Sayı: 3 Sayfa Aralığı: 258 - 264 Metin Dili: İngilizce DOI: 10.14744/etd.2023.56313 İndeks Tarihi: 10-07-2023

Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study

Öz:
Objective: The term post-COVID (coronavirus disease) is used to refer to the presence of prolonged symptoms 12 weeks or more after the disease treatment. This study aimed to evaluate the presence of symptoms and anxiety in patients with COVID-19 who did not require inpatient care at the third and sixth months following symptom onset. Materials and Methods: The study is a prospective cohort study involving 471 university employees who contracted COVID-19 between October 2020 and October 2021. Data were obtained through the disease contact follow-up program implemented at the university and phone interviews conducted at the third and sixth months from symptom onset. Results: The study group comprised 361 individuals at three months and 109 at six months from symptom onset. The study found that symptoms persisted in 116 (32.1%) people in the third month and in 47 (13.0%) people in the sixth month. The most common symptoms at three months were shortness of breath, fatigue, and fatigue, while fatigue, fatigue, and shortness of breath were the most common symptoms at six months. Conclusion: Understanding the long-term effects of coronavirus will enhance the management of the disease. As a result, the follow-up of symptomatic COVID-19 and post-COVID-19 patients will become more systematic and effective.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Lamprecht B. Is there a post-COVID syndrome?. Pneumologe (Berl) 2020; 17(6): 398–405.
  • 2. Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci 2020; 21: 100276.
  • 3. COVID-19 Rapid Guideline: Managing the long-term effects of COVID-19: National Institute of Health and Care Exellence. Available from: URL: https://www.nice.org.uk/guidance/ng188. Accessed Jun 27, 2021.
  • 4. Mahase E. Covid-19: What do we know about “long covid”?. BMJ 2020; 370: m2815.
  • 5. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et all. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet 2020; 395(10227): 912–20.
  • 6. Jiang DH, McCoy RG. Planning for the post-COVID syndrome: How payers can mitigate long-term complications of the pandemic. J Gen Intern Med 2020; 35(10): 3036–9.
  • 7. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019.
  • 8. McCorkell L, S Assaf G, E Davis H, Wei H, Akrami A. patient-led research collaborative: Embedding patients in the Long COVID narrative. Pain Rep 2021; 6(1): e913.
  • 9. Lee SA. Coronavirus anxiety scale: A brief mental health screener for COVID-19 related anxiety. Death Stud 2020; 44(7): 393–401.
  • 10. Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Measuring anxiety related to COVID-19: A Turkish validation study of the Coronavirus anxiety scale. Death Stud 2022; 46(5): 1052–8.
  • 11. Abdullah U, Arslan Ş, Manap HS, Gürkan T, Çalışkan M, Dayioğlu A, et al. A interactive web based dashboard for Covid-19 Pandemic real time monitorization in Turkey: TURCOVID19. Anatol Clin J Med Scien 2020; 25(Special Issue on COVID 19): 154–5.
  • 12. World Health Organization (WHO). Tracking SARS-CoV-2 variants. Available from: URL: www.who.int/en/activities/tracking-SARS-CoV- 2-variants/. Accessed Apr 7, 2023.
  • 13. Carod-Artal FJ. Post-COVID-19 syndrome: Epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol 2021; 72(11): 384–96.
  • 14. Fernández-de-Las-Peñas C, Pellicer-Valero OJ, Navarro-Pardo E, Palacios- Ceña D, Florencio LL, Guijarro C, et al. Symptoms experienced at the acute phase of SARS-CoV-2 infection as risk factor of long-term post-COVID symptoms: The LONG-COVID-EXP-CM multicenter study. Int J Infect Dis 2022; 116: 241–4.
  • 15. Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76(4): 399–401.
  • 16. Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122.
  • 17. Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: What is Long-COVID and how should we manage it?. Lung 2021; 199(2): 113–9.
  • 18. Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A, et al. Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection. 2022; 50(3): 661–9.
  • 19. Bansal AS, Bradley AS, Bishop KN, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun 2012; 26(1): 24–31.
  • 20. Jacob L, Koyanagi A, Smith L, Tanislav C, Konrad M, van der Beck S, et al. Prevalence of, and factors associated with, long-term COVID-19 sick leave in working-age patients followed in general practices in Germany. Int J Infect Dis 2021; 109: 203–8.
  • 21. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021; 53(10): 737–54.
  • 22. Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med 2020; 174: 106197.
  • 23. Galal I, Hussein AAM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egyptian J Bronchology 2021; 15(1): 1–8.
  • 24. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109(5): 531–8.
  • 25. Varatharaj A, Thomas N, Ellul MA, Davies NW, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry 2020; 7(10): 875–82.
  • 26. Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al; Writing Committee for the COMEBAC Study Group. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 2021; 325(15): 1525–34.
  • 27. Asmundson GJ, Taylor S. Coronaphobia: Fear and the 2019-nCoV outbreak. J Anxiety Disorders 2020; 70: 102196.
  • 28. Feliciano L, Johanson KA, Okun ML, Walden A. Impacts of the coronavirus pandemic on the emotional and physical health of older adults compared with younger cohorts. Clin Gerontol 2022; 45(1): 45–57.
  • 29. Palas Karaca P, Koyucu RG, Aksu SÇ. The relationship between pregnant women’s anxiety levels about coronavirus and prenatal attachment. Arch Psychiatr Nurs 2022; 36: 78–84.
  • 30. Ahn MH, Lee J, Suh S, Lee S, Kim HJ, Shin YW, Chung S. Application of the stress and anxiety to viral epidemics-6 (SAVE-6) and Coronavirus Anxiety Scale (CAS) to measure anxiety in ca
APA Öznur Muz F, Metintas S, Onsuz M, Ünsal A, arslantas d, Kılınç A, GÖLBAŞI KOÇ S, Sungur S (2023). Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. , 258 - 264. 10.14744/etd.2023.56313
Chicago Öznur Muz Feyza Nehir,Metintas Selma,Onsuz Muhammed Fatih,Ünsal Alaettin,arslantas didem,Kılınç Ali,GÖLBAŞI KOÇ Selva Dilan,Sungur Sevda Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. (2023): 258 - 264. 10.14744/etd.2023.56313
MLA Öznur Muz Feyza Nehir,Metintas Selma,Onsuz Muhammed Fatih,Ünsal Alaettin,arslantas didem,Kılınç Ali,GÖLBAŞI KOÇ Selva Dilan,Sungur Sevda Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. , 2023, ss.258 - 264. 10.14744/etd.2023.56313
AMA Öznur Muz F,Metintas S,Onsuz M,Ünsal A,arslantas d,Kılınç A,GÖLBAŞI KOÇ S,Sungur S Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. . 2023; 258 - 264. 10.14744/etd.2023.56313
Vancouver Öznur Muz F,Metintas S,Onsuz M,Ünsal A,arslantas d,Kılınç A,GÖLBAŞI KOÇ S,Sungur S Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. . 2023; 258 - 264. 10.14744/etd.2023.56313
IEEE Öznur Muz F,Metintas S,Onsuz M,Ünsal A,arslantas d,Kılınç A,GÖLBAŞI KOÇ S,Sungur S "Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study." , ss.258 - 264, 2023. 10.14744/etd.2023.56313
ISNAD Öznur Muz, Feyza Nehir vd. "Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study". (2023), 258-264. https://doi.org/10.14744/etd.2023.56313
APA Öznur Muz F, Metintas S, Onsuz M, Ünsal A, arslantas d, Kılınç A, GÖLBAŞI KOÇ S, Sungur S (2023). Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. Journal of clinical practice and research, 45(3), 258 - 264. 10.14744/etd.2023.56313
Chicago Öznur Muz Feyza Nehir,Metintas Selma,Onsuz Muhammed Fatih,Ünsal Alaettin,arslantas didem,Kılınç Ali,GÖLBAŞI KOÇ Selva Dilan,Sungur Sevda Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. Journal of clinical practice and research 45, no.3 (2023): 258 - 264. 10.14744/etd.2023.56313
MLA Öznur Muz Feyza Nehir,Metintas Selma,Onsuz Muhammed Fatih,Ünsal Alaettin,arslantas didem,Kılınç Ali,GÖLBAŞI KOÇ Selva Dilan,Sungur Sevda Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. Journal of clinical practice and research, vol.45, no.3, 2023, ss.258 - 264. 10.14744/etd.2023.56313
AMA Öznur Muz F,Metintas S,Onsuz M,Ünsal A,arslantas d,Kılınç A,GÖLBAŞI KOÇ S,Sungur S Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. Journal of clinical practice and research. 2023; 45(3): 258 - 264. 10.14744/etd.2023.56313
Vancouver Öznur Muz F,Metintas S,Onsuz M,Ünsal A,arslantas d,Kılınç A,GÖLBAŞI KOÇ S,Sungur S Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study. Journal of clinical practice and research. 2023; 45(3): 258 - 264. 10.14744/etd.2023.56313
IEEE Öznur Muz F,Metintas S,Onsuz M,Ünsal A,arslantas d,Kılınç A,GÖLBAŞI KOÇ S,Sungur S "Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study." Journal of clinical practice and research, 45, ss.258 - 264, 2023. 10.14744/etd.2023.56313
ISNAD Öznur Muz, Feyza Nehir vd. "Prevalence of Post-COVID-19 Syndrome and Related Factors among University Employees: A Prospective Cohort Study". Journal of clinical practice and research 45/3 (2023), 258-264. https://doi.org/10.14744/etd.2023.56313